New hope for PNH patients battling anemia
NCT ID NCT05876312
Summary
This early-stage study is testing a new drug called ADX-038. First, it checks for safety in healthy volunteers. Then, it will be given to a small group of people with PNH who still have anemia despite being on their current standard medication. The main goal is to see if the drug is safe and how it affects the body and blood levels.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Nucleus Network Brisbane
Brisbane, Queensland, 4006, Australia
-
Peter MacCallum Cancer Centre
Melbourne, Victoria, 3000, Australia
-
Richmond Pharmacology Ltd
London, London, SE1 1YR, United Kingdom
-
Royal Melbourne Hospital
Parkville, Victoria, 3052, Australia
Conditions
Explore the condition pages connected to this study.